CClinicalTrials.gg
CompletedNCT04513249Updated Aug 14, 2020

Effects of Therapeutic Plasmaexhange on Viscoelastic Tests in Non-coagulopathic Patients

An observational study in Transfusion Related Complication, sponsored by Institutul Clinic Fundeni. Completed at 1 site in Romania. Open to participants aged 18 Minutes and older. Per ClinicalTrials.gov, last updated 2020-08-14.

Sponsored by Institutul Clinic Fundeni · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
25
Ages
18 Minutes and older
Sex
All
01

Study summary

Therapeutic plasma exchange is widely performed in patients with autoimmune disease. The exact effects of fresh frozen plasma on coagulation in this group of patients remains unknown. In order to investigate this issue the present study monitors periprocedural coagulation status with the aid of standard coagulation tests and rotational thromboelastometry. Four thromboelastometric tests will be performed: ExTEM, InTEM, FibTEM and ApTEM. The following parameters will be recorded from each test: CT (sec), CFT (sec) and MCF (mm) one hour before and one hour after plasmaechange was performed.

02

Conditions studied

  • Transfusion Related Complication
03

In context

Lead sponsor

Institutul Clinic Fundeni is the lead sponsor of 7 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Minutes and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

consecutive patients undergoing therapeutic plasmaechange for autoimmune disease

Inclusion criteria

  • patients undergoing therapeutic plasma exchange for autoimmune disease

Exclusion criteria

Exclusion Criteria:

  • previous coagulation disorders
  • anticoagulant or antiplatelet therapy within the last 7 days
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
25 participants (actual)
Patient registry
No

Interventions

  • Diagnostic testdynamics of coagulation parameters

    the effects of fresh frozen plasma administered during a plasma exchange therapy on viscoelastic tests

06

What researchers measure

Primary outcomes

  1. change in clotting time - CT (%)

    change in CT determined before and after plasmaexchange. A 20% change in parameter value will be considered clinically significant.

    Time frame: one hour before compared to one hour after plasmaexchange

Secondary outcomes

  1. change clot formation time - CFT (%)

    change in CFT determined before and after plasmaexchange. A 20% change in parameter value will be considered clinically significant.

    Time frame: one hour before compared to one hour after plasmaexchange

  2. change maximum clot firmness - MCF (%)

    change in MCF determined before and after plasmaexchange. A 20% change in parameter value will be considered clinically significant.

    Time frame: one hour before compared to one hour after plasmaexchange

07

Study locations

1 site
  • Fundeni Clinical Institute
    Bucharest, 022328, Romania
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 14, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04513249
Lead sponsor
Institutul Clinic Fundeni
Responsible party
Popescu Mihai (Clinical Professor, Institutul Clinic Fundeni) — Principal investigator
First posted
Aug 14, 2020
Start date
May 10, 2017
Primary completion
Dec 30, 2017
Completion
Dec 30, 2017
Last update
Aug 14, 2020

Study contacts

Dana Tomescu, Prof
study chair · Fundeni Clinical Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion